title: Immunovirological parameters and cytokines in HIV infection.
abstract: Although modern combined antiretroviral therapies (cART) result in lower morbidity and mortality and a visible improvement of clinical and laboratory parameters in HIV-infected, it is known that their long-term use contributes to appearance of the many events unrelated to AIDS such as cardiovascular diseases, cancer and osteoporosis, comorbidities which have been proposed as some of the most important that deprive the majority of infected to present an even better prognosis. This is because even with a decrease in inflammation and immune activation after drug intervention to the patient, these parameters remain higher than those shown by healthy individuals and the imbalance of cytokine profiles also persists. Therefore, evaluations of other biomarkers in clinical practice are needed to complement the exams already carried out routinely and allow more effective monitoring of HIV patients. This review aims to investigate the role of cytokines as potential markers showing studies on their behavior in various stages of HIV infection, with or without cART.
authors.affiliation: Departamento de Doenças Tropicais, Faculdade de Medicina de Botucatu, Universidade Estadual Paulista, Botucatu, SP. karenitasca@hotmail.com
authors.forename: Karen Ingrid
authors.initials: KI
authors.lastname: Tasca
authors.forename: Sueli Aparecida
authors.initials: SA
authors.lastname: Calvi
authors.forename: Lenice do Rosário de
authors.initials: Ldo R
authors.lastname: Souza
mesh_terms: D023241:Antiretroviral Therapy, Highly Active; D015415:Biomarkers / Q000097:blood; D015496:CD4-Positive T-Lymphocytes / Q000276:immunology; D018414:CD8-Positive T-Lymphocytes / Q000276:immunology; D016207:Cytokines / Q000097:blood / Q000276:immunology*; D018450:Disease Progression; D015658:HIV Infections / Q000097:blood / Q000188:drug therapy / Q000276:immunology*; D006801:Humans; D019562:Viral Load
chemical_list: D015415:Biomarkers; D016207:Cytokines